Step Therapy Criteria Commonwealth Care Alliance 2013 Last Updated: 03/2013 Effective: April 1, 2013 CCA ANTIDEPRESSANT (SNRI) ST 2013C Products Affected Criteria
Patient needs to have paid claims for one of the following Step 1 drugs
with a day supply of at least 30 days prior to filling a Step 2 drug. Step 1
drugs: citalopram, citalopram Hbr, escitalopram, fluoxetine Dr, fluoxetine
Hcl, fluvoxamine maleate, paroxetine Hcl, Rapiflux, sertraline Hcl,
venlafaxine Hcl, venlafaxine Hcl Er. Step 2 Drugs: Cymbalta, Pristiq,
Savella. Patients who have taken a step 2 drug at any time in the past may
restart. Authorization may be given for a step 2 drug if the patient is
currently taking the requested agent. Patients aged 18 years of less:
approve Cymbalta or Pristiq without a trial of a step 1 agent. Symptoms
of suicidal ideation: approve Cymbalta or Pristiq without a trial of a step 1
agent. Stress urinary incontinence: approve Cymbalta without a trial of a
step 1 agent. Fibromyalgia: approve Cymbalta or Savella without a trial of
a step 1 agent. Chronic musculoskeletal pain (eg, low back pain or pain
due to osteoarthritis): approve Cymbalta without a trial of a step 1 agent.
Chronic musculoskeletal pain (eg, low back pain or pain due to
osteoarthritis) and Diabetic peripheral neuropathy: approve Cymbalta
CCA BISPHOSPHONATES 2013S Products Affected Criteria
Patient needs to have a paid claim for one of the following Step 1 drugs
prior to filling a Step 2 drug. Step 1 drugs: alendronate, ibandronate. Step
CCA NASAL CORTICOSTERIODS ST 2013S Products Affected Criteria
Patient needs to have a paid claim for one of the following Step 1 drugs
prior to filling a Step 2 drug. Step 1 drugs: flunisolide, fluticasone
propionate, Nasonex, Rhinocort Aqua, Veramyst, triamcinolone. Step 2
CCA SEDATIVE HYPNOTICS ST 2013S Products Affected Criteria
Patient needs to have a paid claim for one of the following Step 1 drugs
prior to filling a Step 2 drug. Step 1 drugs: generic zolpidem (including
zolpidem CR) or zaleplon. Step 2 drugs: Rozerem, Edluar, Zolpimist.
CCA SSRI ANTIDEPRESSANTS (SSRI) ST 2013S Products Affected Criteria
Patient needs to have paid claims for one of the following Step 1 drugs
(must be generic) with a day supply of at least 30 days prior to filling a
Step 2 drug. Step 1 drugs: citalopram hydrobromide, escitalopram,
fluoxetine HCL, fluvoxamine maleate, paroxetine HCL, paroxetine ER,
sertraline HCL.Step 2: Luvox CR, Viibryd.
A O P B S C
Cca Bisphosphonates 2013s . 2 Cca Nasal Corticosteriods St 2013s . 3
V
Cca Ssri Antidepressants (ssri) St 2013s . 5 Cymbalta . 1
Z L
PERSISTENT ORGANIC COMPOUNDS IN WASTEWATER: AZITHROMYCIN AND UROBILIN CONCENTRATIONS IN WASTEWATER TREATMENT PLANT SAMPLES FROM MURRAY, KENTUCKY, USA Mowery HR, Loganathan BG Department of Chemistry and Center for Reservoir Research, Murray State University, Murray, KY 42071-3346, USA. Abstract The presence of pharmaceutical and personal care products (PPCPs) in the environment and
New e-mail protections are now available to ensure the safety, privacy and security of corporate networks, data and personnel. The increased sophistication, versatility and effectiveness of e- mail security solutions have been paired with improved ease-of- use, providing a transparent, simply managed barrier against spam, phishing and other inbound e-mail-based attacks as well as outboun
Step Therapy Criteria 
CCA BISPHOSPHONATES 2013S 
CCA NASAL CORTICOSTERIODS ST 2013S 
CCA SEDATIVE HYPNOTICS ST 2013S 
CCA SSRI ANTIDEPRESSANTS (SSRI) ST 2013S